The Pharmaceuticals Native Starch Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Pharmaceuticals Native Starch Global Market Report 2025 has seen robust growth in recent years. The market increased from $5.65 billion in 2024 to $6.17 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.1%.
The Pharmaceuticals Native Starch Global Market is projected to grow to a market size of $8.69 billion in 2029, with a compound annual growth rate (CAGR) of 8.9%.
Download Your Free Sample of the 2025 Pharmaceuticals Native Starch Market Report and Uncover Key Trends Now!The key drivers in the pharmaceuticals native starch market are:
• Rising investments in pharmaceutical innovation
• Growing focus on sustainable sourcing in the pharmaceutical sector
• Increasing applications of native starch in novel drug formulations
• Rising demand for clean-label pharmaceutical products.
The pharmaceuticals native starch market covered in this report is segmented –
1) By Type: Potato Starch, Corn Starch, Other Types
2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users
The key trends in the pharmaceuticals native starch market are:
• Advancements in starch processing technology are making an impact on the market.
• Innovations in drug delivery systems are emerging as a strong trend.
• There is increasing development in bio-based pharmaceutical ingredients.
• Research and development in plant-based excipients are becoming more prevalent.
Major players in the pharmaceuticals native starch market are:
• Cargill Incorporated
• Archer Daniels Midland Company
• Ingredion Incorporated
• Tereos SCA
• Roquette Frères SA.
• AGRANA
• Tate & Lyle Public Limited Company
• Colorcon Inc.
• Grain Processing Corporation
• Siam Modified Starch Co. Ltd.
• BENEO GmbH
• Gulshan Polyols Ltd.
• SPAC Starch Products (India) Private Limited
• Universal Starch-Chem Allied Ltd.
• Sanstar Biopolymers Ltd.
• Emsland Group
• Hungrana Kft.
• Bluecraft Agro Pvt. Ltd.
• Visco Starch
• Shandong Liujia Pharmaceutical Excipient Co.Ltd.
North America was the largest region in the pharmaceuticals native starch market in 2024